PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Maria Luisa Gasparri(Ospedale regionale di Lugano), Pierluigi Benedetti Panici(Policlinico Umberto I), Andrea Papadia(University of Bern), Ilary Ruscito(Sapienza University of Rome), Michael D. Mueller(University of Bern), Erlisa Bardhi(Sapienza University of Rome), Ammad Ahmad Farooqı(Institute of Biomedical and Genetic Engineering), Giorgio Bogani(Fondazione IRCCS Istituto Nazionale dei Tumori), Cláudia Marchetti(Sapienza University of Rome), Irene Ceccacci(Sapienza University of Rome)
Cited by 134
Related Papers
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres
|Human Reproduction|2012|1.1k
Robot-assisted Sacrocolpopexy for Pelvic Organ Prolapse: A Systematic Review and Meta-analysis of Comparative Studies
|European Urology|2014|183
Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: A systematic review and meta-analysis
|Gynecologic Oncology|2014|181
Vaginal Cuff Dehiscence in a Series of 12,398 Hysterectomies
|Obstetrics and Gynecology|2012|179
Role of pelvic and para‐aortic lymphadenectomy in endometrial cancer: Current evidence
|Journal of obstetrics and gynaecology research|2014|175